Stocks and Finance

Icagen

Icagen 9/6/2011

13:04 : Pfizer ([[PFE]] +0.5%) says its $6 tender offer for shares of Icagen ([[IC - Pfizer (PFE +0.5%) says its $6 tender offer for shares of Icagen (ICGN +0.2%) is successful after it needed two extensions to get a controlling interest of the company. A new offering period was initiated by the company at ...
Source : seekingalpha-com

Icagen 9/1/2011

09:47 : Pfizer's offer for Icagen is extended - Pfizer has extended the deadline for its $6-per-share offer for Durham's Icagen by 24 hours in hopes of winning the support of more shareholders so it can complete the deal.
Source : newsobserver-com

Icagen 8/26/2011

13:12 : Pfizer sticks to $6/share offer for Icagen - (Reuters) - Pfizer Inc has informed Icagen's board that its best and final offer price for the biopharmaceutical company was $6 a share and that it would not pay more.
Source : reuters-com

Icagen 8/19/2011

02:02 : Icagen sought many suitors - Durham drug-development company Icagen approached dozens of companies during the past three years about a possible acquisition before finally announcing its takeover by Pfizer last month.
Source : newsobserver-com

Icagen 8/1/2011

06:18 : Icagen investors seek higher price than Pfizer's offer - Two large Icagen investors say that Pfizer's $56 million takeover offer for the Durham drug-development company is too low and will push for a higher price.
Source : newsobserver-com

Icagen 7/21/2011

01:22 : Pfizer to buy Icagen for $56M - Icagen, which was once one of the Triangle's most promising drug-development companies, has agreed to be bought by its larger partner Pfizer for about $56 million.
Source : newsobserver-com

Icagen 7/20/2011

11:59 : Pfizer to buy pain drug developer Icagen for $56M - TRENTON, N.J. (AP) -- Pfizer Inc. said Wednesday that it's reached a definitive agreement to buy Icagen, a small biopharmaceutical company that's developing pain medicines....
Source : usnews-com
09:26 : Pfizer to buy Durham's Icagen for $56 million - Icagen agreed to be bought by its larger partner Pfizer for $6 per share, or about $56 million, a price that's less than what Wall Street was expecting.
Source : newsobserver-com
08:43 : Icagen plunges on Pfizer takeover terms - BOSTON (MarketWatch)-- After being bid sky-high in anticipation of a merger deal, shares of Icagen Inc. plunged 23% to $5.96 in premarket trading Wednesday on news that Pfizer Inc. plans to buy the biotech group for $6 a share. ...
Source : marketwatch-com

Icagen 7/14/2011

10:20 : Icagen up 14% in morning trading - BOSTON (MarketWatch) -- Shares of Icagen Inc. were up 14% at $6.90 Thursday. The stock has shot up nearly 200% over the past month on speculation that it will soon be bought by development partner Pfizer Inc. , which already ...
Source : marketwatch-com

Icagen 6/27/2011

09:59 : Icagen shares jump on potential deal with Pfizer - (Reuters) - Shares of Icagen Inc jumped for the second day -- more than doubling on Monday -- as investors cheered the possibility of the biotech firm inking a deal with Pfizer Inc .
Source : reuters-com
08:58 : Icagen rockets 130% on Pfizer talks - BOSTON (MarketWatch) -- Shares of Icagen Inc. rocketed a litte over 130% to $5.58 early Monday on Friday's news that the company and Pfizer Inc. are in talks over a possible merger or expansion of their existing collaboration. ...
Source : marketwatch-com
08:26 : Icagen (ICGN) shares +141.7% premarket after Pfizer (PFE) disclosed in ... - Icagen (ICGN) shares +141.7% premarket after Pfizer (PFE) disclosed in a regulatory filing late Friday that it is discussing a possible "strategic transaction" with the biopharmaceutical company that could result in an asset ...
Source : seekingalpha-com

Icagen 6/25/2011

03:44 : Icagen talks with Pfizer about takeover - Icagen, a Durham drug-development company that has struggled financially, is in discussions about a possible takeover by its much-larger partner Pfizer.
Source : newsobserver-com

Icagen 6/24/2011

18:10 : Icagen discusses possible sale to partner Pfizer - Icagen, a Durham drug development company that has struggled financially, is in discussions about a possible takeover by its much-larger partner Pfizer.
Source : newsobserver-com
actualidad Icagen -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts